Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declared that FDA said additional data are need as part of the New Drug Application or NDA submission for Eteplirsen, comprising the results from an independent assessment of dystrophin images and the 168-week clinical data from study 202. As well, FDA requested for more specific data, including a minimum duration of safety in new patients uncovered to eteplirsen, patient-level natural history data and MRI data from a recent study conducted by an independent academic group. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock has highest price of $16.68 in last session, beginning with a price of $14.80 and reported a decrease of -32.47% to the closed at $15.91 with a day range of $14.74-$16.68.Vodafone Group Plc (ADR) (NASDAQ:VOD) released that it has begun an audit into probable tax fraud at Spanish cable operator Grupo Corporativo Ono SA, which the UK-based telecom giant bought in July. The investigation is related with value-added tax declarations that Ono made. Shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) traded at $31.89 by plunging -1.15% with price volatility of 1.05% for a week and 1.71% for a month. Its beta stands at 0.80 times.CTI BioPharma Corp. (NASDAQ:CTIC) announced on Monday that it has purchased global rights to tosedostat through concurrent transactions with Vernalis R&D Ltd. Tosedostat is a Selective Oral Anti-Cancer Therapy.bVernalis is the originator of tosedostat, and it is Chroma Therapeutics Ltd.. Through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America. CTI BioPharma Corp. (NASDAQ:CTIC) stock hit highest price at $2.42, beginning with a price of $2.42 and reported an increase of 0.42% to the closed at $2.41 with a day range of $2.35-$2.42. The total market capitalization remained 348.1 Million, total volume of 518015 shares held in the session was surprisingly higher than its average volume of 1086.37 shares.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
